Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

Abstract Background Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with peripheral artery disease treated with ci...

Full description

Bibliographic Details
Main Authors: Jordi Real, M Catalina Serna, Maria Giner-Soriano, Rosa Forés, Guillem Pera, Esther Ribes, Maite Alzamora, Josep Ramon Marsal, Antonio Heras, Rosa Morros
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Cilostazol
Pentoxifylline
Peripheral artery disease
Primary healthcare
Electronic health records
Haemorrhage
Online Access:http://link.springer.com/article/10.1186/s12872-018-0822-4

Internet

http://link.springer.com/article/10.1186/s12872-018-0822-4

Similar Items